WS Audiology loses USD 600m across two years – still withholds net profit guidance
Hearing-aid manufacturer WS Audiology has operated with resounding losses in its two years after the Widex-Sivantos merger, but the executive team declines to comment on when the group expects to present black bottom-line figures. Interest-bearing debt of EUR 3.6bn makes it tough to predict, the company says.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY DANIEL FRANK CHRISTENSEN
It's been poor business as of late, to put it mildly, being hearing-aid manufacturer WS Audiology, which following the major merger of Danish Widex and EQT-owned Sivantos from Germany – which became a reality in 2019 – could otherwise claim the title as the world's third-largest hearing-aid supplier.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
